Interaction Color Code
Clinical Bottom Line
Do not coadminister: Potential for reduced antiviral activity
Drug 1
Drug 1 effect
Not studied
Drug 2 effect
Not studied (may decrease paritaprevir levels)
Clinical Effects
Significant GI and neurologic adverse events occurred, increase ALT
Management
Contraindicated. Use alternative agents.
Import ID
433
